Class & Mechanism
PE 22-28, also known as PreproEnkephalin 22-28 or Davunetide-related peptide, is a fragment of the precursor protein of enkephalins, which are endogenous opioids. PE 22-28 is thought to have analgesic effects by modulating opioid receptors, particularly the delta-opioid receptor [3][4].
Research-documented benefits
– PE 22-28 has been shown to have analgesic effects in various pain models [3][4].
General-knowledge benefits
– The peptide may have potential therapeutic applications in pain management and as an adjunct to traditional analgesics.
– PE 22-28 could be useful in conditions where opioid analgesics are beneficial, such as chronic pain, cancer pain, or postoperative pain.
Typical injectable protocol
Research-only. The exact dosing protocol is not standardized and varies based on the study design and animal models used.
Key risks / contraindications
– As a peptide with opioid activity, PE 22-28 may have potential side effects such as respiratory depression, constipation, and dependence.
– It should be used with caution in individuals with a history of substance abuse or those taking other opioids.
Bottom line
PE 22-28 is a peptide with potential analgesic effects, but its therapeutic applications and safety profile require further research and clinical trials.
References
- Basic and Clinical Aspects of Growth Hormone
- Boundless Upgrade Your Brain, Optimize Your Body and Defy — Ben Greenfield
- Growth Hormone Secretagogues
- Growth Hormone Secretagogues in Clinical Practice
- Handbook of Biologically Active Peptides
- Handbook of Neurochemistry and Molecular Neurobiology_ Neurotransmitter Systems
- Kosmetik für Ärzte und Apotheker
- Life Force
- Molecular Neuroscience
- Neuroprotective Effects of Tripeptides—Epigenetic Regulators — Khavinson, Vladimir (author)
- Peptide Protocols Volume One — William A Seeds MD
- Peptide drug discovery and development _ Translational — edited by Miguel Castanho and
- Peptides_ Chemistry and Biology, 2nd Edition
- Pharmacological Sciences_ Perspectives for Research and Therapy in the Late 1990s
- The Perricone Prescription
- The glucagon-like peptides
